Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference

Provided By PR Newswire

Last update: Jun 16, 2023

SAN DIEGO, June 16, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President and CEO, Robert E. Hoffman and its Chief Scientific Officer, Dennis Brown, Ph.D., will participate in a fireside chat at the Maxim Group Virtual Conference on Tuesday, June 20, 2023 at 4:30 pm ET.